APO Research
Talk to an analyst

APO RESEARCH · REPORT

Synovial Sarcoma Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Synovial Sarcoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchSynovial Sarcoma Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Synovial Sarcoma Treatment Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Synovial Sarcoma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Synovial Sarcoma Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Synovial Sarcoma Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Synovial Sarcoma Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Synovial Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Synovial Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Synovial Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Synovial Sarcoma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Synovial Sarcoma Treatment include Johnson & Johnson, Novartis AG, Merck & Co Inc, Pfizer Inc, Takara Bio Inc, Millennium Pharmaceuticals Inc, Karyopharm Therapeutics Inc, Immunocore Ltd and Immune Design Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Synovial Sarcoma Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Synovial Sarcoma Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Synovial Sarcoma Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Synovial Sarcoma Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Synovial Sarcoma Treatment Segment by Company

Johnson & Johnson

Novartis AG

Merck & Co Inc

Pfizer Inc

Takara Bio Inc

Millennium Pharmaceuticals Inc

Karyopharm Therapeutics Inc

Immunocore Ltd

Immune Design Corp

EpiZyme Inc

Advenchen Laboratories LLC

Adaptimmune Therapeutics Plc

Synovial Sarcoma Treatment Segment by Type

ACXT-3102

AL-3818

CMB-305

CUE-102

Axitinib

Others

Synovial Sarcoma Treatment Segment by Application

Hospital

Clinic

Others

Synovial Sarcoma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synovial Sarcoma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Synovial Sarcoma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synovial Sarcoma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Synovial Sarcoma Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Synovial Sarcoma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Synovial Sarcoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Synovial Sarcoma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Synovial Sarcoma Treatment Industry Trends Table 2. Synovial Sarcoma Treatment Industry Drivers Table 3. Synovial Sarcoma Treatment Industry Opportunities and Challenges Table 4. Synovial Sarcoma Treatment Industry Restraints Table 5. Global Synovial Sarcoma Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Synovial Sarcoma Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Synovial Sarcoma Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Synovial Sarcoma Treatment Sales Market Share by Manufacturers Table 9. Global Synovial Sarcoma Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Synovial Sarcoma Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Synovial Sarcoma Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Synovial Sarcoma Treatment Manufacturers, Product Type & Application Table 13. Global Synovial Sarcoma Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Synovial Sarcoma Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ACXT-3102 Table 17. Major Manufacturers of AL-3818 Table 18. Major Manufacturers of CMB-305 Table 19. Major Manufacturers of CUE-102 Table 20. Major Manufacturers of Axitinib Table 21. Major Manufacturers of Others Table 22. Global Synovial Sarcoma Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Synovial Sarcoma Treatment Sales by Type (2021-2026) & (k units) Table 24. Global Synovial Sarcoma Treatment Sales by Type (2027-2032) & (k units) Table 25. Global Synovial Sarcoma Treatment Sales Market Share by Type (2021-2026) Table 26. Global Synovial Sarcoma Treatment Sales Market Share by Type (2027-2032) Table 27. Global Synovial Sarcoma Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Synovial Sarcoma Treatment Revenue by Type (2021-2026) & (k units) Table 29. Global Synovial Sarcoma Treatment Revenue by Type (2027-2032) & (k units) Table 30. Global Synovial Sarcoma Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Synovial Sarcoma Treatment Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Clinic Table 34. Major Manufacturers of Others Table 35. Global Synovial Sarcoma Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Synovial Sarcoma Treatment Sales by Application (2021-2026) & (k units) Table 37. Global Synovial Sarcoma Treatment Sales by Application (2027-2032) & (k units) Table 38. Global Synovial Sarcoma Treatment Sales Market Share by Application (2021-2026) Table 39. Global Synovial Sarcoma Treatment Sales Market Share by Application (2027-2032) Table 40. Global Synovial Sarcoma Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Synovial Sarcoma Treatment Revenue by Application (2021-2026) & (k units) Table 42. Global Synovial Sarcoma Treatment Revenue by Application (2027-2032) & (k units) Table 43. Global Synovial Sarcoma Treatment Revenue Market Share by Application (2021-2026) Table 44. Global Synovial Sarcoma Treatment Revenue Market Share by Application (2027-2032) Table 45. Global Synovial Sarcoma Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Synovial Sarcoma Treatment Sales by Region (2021-2026) & (k units) Table 47. Global Synovial Sarcoma Treatment Sales Market Share by Region (2021-2026) Table 48. Global Synovial Sarcoma Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Synovial Sarcoma Treatment Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Synovial Sarcoma Treatment Sales by Country (2021-2026) & (k units) Table 52. North America Synovial Sarcoma Treatment Sales by Country (2027-2032) & (k units) Table 53. Europe Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Synovial Sarcoma Treatment Sales by Country (2021-2026) & (k units) Table 55. Europe Synovial Sarcoma Treatment Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Synovial Sarcoma Treatment Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Synovial Sarcoma Treatment Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2027-2032) & (k units) Table 62. Global Synovial Sarcoma Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Synovial Sarcoma Treatment Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Synovial Sarcoma Treatment Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Synovial Sarcoma Treatment Revenue Market Share by Region (2021-2026) Table 66. Global Synovial Sarcoma Treatment Revenue Market Share by Region (2027-2032) Table 67. Johnson & Johnson Company Information Table 68. Johnson & Johnson Business Overview Table 69. Johnson & Johnson Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Johnson & Johnson Synovial Sarcoma Treatment Product Portfolio Table 71. Johnson & Johnson Recent Development Table 72. Novartis AG Company Information Table 73. Novartis AG Business Overview Table 74. Novartis AG Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Novartis AG Synovial Sarcoma Treatment Product Portfolio Table 76. Novartis AG Recent Development Table 77. Merck & Co Inc Company Information Table 78. Merck & Co Inc Business Overview Table 79. Merck & Co Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Merck & Co Inc Synovial Sarcoma Treatment Product Portfolio Table 81. Merck & Co Inc Recent Development Table 82. Pfizer Inc Company Information Table 83. Pfizer Inc Business Overview Table 84. Pfizer Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Inc Synovial Sarcoma Treatment Product Portfolio Table 86. Pfizer Inc Recent Development Table 87. Takara Bio Inc Company Information Table 88. Takara Bio Inc Business Overview Table 89. Takara Bio Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Takara Bio Inc Synovial Sarcoma Treatment Product Portfolio Table 91. Takara Bio Inc Recent Development Table 92. Millennium Pharmaceuticals Inc Company Information Table 93. Millennium Pharmaceuticals Inc Business Overview Table 94. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product Portfolio Table 96. Millennium Pharmaceuticals Inc Recent Development Table 97. Karyopharm Therapeutics Inc Company Information Table 98. Karyopharm Therapeutics Inc Business Overview Table 99. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product Portfolio Table 101. Karyopharm Therapeutics Inc Recent Development Table 102. Immunocore Ltd Company Information Table 103. Immunocore Ltd Business Overview Table 104. Immunocore Ltd Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Immunocore Ltd Synovial Sarcoma Treatment Product Portfolio Table 106. Immunocore Ltd Recent Development Table 107. Immune Design Corp Company Information Table 108. Immune Design Corp Business Overview Table 109. Immune Design Corp Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Immune Design Corp Synovial Sarcoma Treatment Product Portfolio Table 111. Immune Design Corp Recent Development Table 112. EpiZyme Inc Company Information Table 113. EpiZyme Inc Business Overview Table 114. EpiZyme Inc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. EpiZyme Inc Synovial Sarcoma Treatment Product Portfolio Table 116. EpiZyme Inc Recent Development Table 117. Advenchen Laboratories LLC Company Information Table 118. Advenchen Laboratories LLC Business Overview Table 119. Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Advenchen Laboratories LLC Synovial Sarcoma Treatment Product Portfolio Table 121. Advenchen Laboratories LLC Recent Development Table 122. Adaptimmune Therapeutics Plc Company Information Table 123. Adaptimmune Therapeutics Plc Business Overview Table 124. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product Portfolio Table 126. Adaptimmune Therapeutics Plc Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Synovial Sarcoma Treatment Distributors List Table 130. Synovial Sarcoma Treatment Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Synovial Sarcoma Treatment Product Image Figure 2. Global Synovial Sarcoma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Synovial Sarcoma Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Synovial Sarcoma Treatment Sales (2021-2032) & (k units) Figure 5. Global Synovial Sarcoma Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Synovial Sarcoma Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ACXT-3102 Image Figure 9. AL-3818 Image Figure 10. CMB-305 Image Figure 11. CUE-102 Image Figure 12. Axitinib Image Figure 13. Others Image Figure 14. Global Synovial Sarcoma Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Synovial Sarcoma Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Synovial Sarcoma Treatment Sales Market Share by Type (2021-2032) Figure 17. Global Synovial Sarcoma Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Synovial Sarcoma Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Synovial Sarcoma Treatment Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Synovial Sarcoma Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Synovial Sarcoma Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Synovial Sarcoma Treatment Sales Market Share by Application (2021-2032) Figure 26. Global Synovial Sarcoma Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Synovial Sarcoma Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Synovial Sarcoma Treatment Revenue Market Share by Application (2021-2032) Figure 29. North America Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Synovial Sarcoma Treatment Sales Market Share by Country (2021-2032) Figure 31. U.S. Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Synovial Sarcoma Treatment Sales Market Share by Country (2021-2032) Figure 36. Germany Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Country (2021-2032) Figure 43. China Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Country (2021-2032) Figure 51. Brazil Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Synovial Sarcoma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Synovial Sarcoma Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Synovial Sarcoma Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Synovial Sarcoma Treatment Revenue (2021-2032) & (US$ Million) Figure 62. North America Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Synovial Sarcoma Treatment Revenue (2021-2032) & (US$ Million) Figure 64. Europe Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Synovial Sarcoma Treatment Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Synovial Sarcoma Treatment Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Synovial Sarcoma Treatment Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Synovial Sarcoma Treatment Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • ACXT-3102
  • AL-3818
  • CMB-305
  • CUE-102
  • Axitinib
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co Inc
  • Pfizer Inc
  • Takara Bio Inc
  • Millennium Pharmaceuticals Inc
  • Karyopharm Therapeutics Inc
  • Immunocore Ltd
  • Immune Design Corp
  • EpiZyme Inc
  • Advenchen Laboratories LLC
  • Adaptimmune Therapeutics Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Synovial Sarcoma Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Synovial Sarcoma Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Synovial Sarcoma Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Synovial Sarcoma Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Synovial Sarcoma Treatment Market Dynamics
  1. 2.1 Synovial Sarcoma Treatment Industry Trends
  2. 2.2 Synovial Sarcoma Treatment Industry Drivers
  3. 2.3 Synovial Sarcoma Treatment Industry Opportunities and Challenges
  4. 2.4 Synovial Sarcoma Treatment Industry Restraints
3 Synovial Sarcoma Treatment Market by Manufacturers
  1. 3.1 Global Synovial Sarcoma Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Synovial Sarcoma Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Synovial Sarcoma Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Synovial Sarcoma Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Synovial Sarcoma Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Synovial Sarcoma Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Synovial Sarcoma Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Synovial Sarcoma Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Synovial Sarcoma Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Synovial Sarcoma Treatment Tier 1, Tier 2, and Tier 3
4 Synovial Sarcoma Treatment Market by Type
  1. 4.1 Synovial Sarcoma Treatment Type Introduction
  2. 4.1.1 ACXT-3102
  3. 4.1.2 AL-3818
  4. 4.1.3 CMB-305
  5. 4.1.4 CUE-102
  6. 4.1.5 Axitinib
  7. 4.1.6 Others
  8. 4.2 Global Synovial Sarcoma Treatment Sales by Type
  9. 4.2.1 Global Synovial Sarcoma Treatment Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Synovial Sarcoma Treatment Sales by Type (2021-2032)
  11. 4.2.3 Global Synovial Sarcoma Treatment Sales Market Share by Type (2021-2032)
  12. 4.3 Global Synovial Sarcoma Treatment Revenue by Type
  13. 4.3.1 Global Synovial Sarcoma Treatment Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Synovial Sarcoma Treatment Revenue by Type (2021-2032)
  15. 4.3.3 Global Synovial Sarcoma Treatment Revenue Market Share by Type (2021-2032)
5 Synovial Sarcoma Treatment Market by Application
  1. 5.1 Synovial Sarcoma Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Synovial Sarcoma Treatment Sales by Application
  6. 5.2.1 Global Synovial Sarcoma Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Synovial Sarcoma Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Synovial Sarcoma Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Synovial Sarcoma Treatment Revenue by Application
  10. 5.3.1 Global Synovial Sarcoma Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Synovial Sarcoma Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Synovial Sarcoma Treatment Revenue Market Share by Application (2021-2032)
6 Global Synovial Sarcoma Treatment Sales by Region
  1. 6.1 Global Synovial Sarcoma Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Synovial Sarcoma Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Synovial Sarcoma Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Synovial Sarcoma Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Synovial Sarcoma Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Synovial Sarcoma Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Synovial Sarcoma Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Synovial Sarcoma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Synovial Sarcoma Treatment Revenue by Region
  1. 7.1 Global Synovial Sarcoma Treatment Revenue by Region
  2. 7.1.1 Global Synovial Sarcoma Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Synovial Sarcoma Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Synovial Sarcoma Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Synovial Sarcoma Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Synovial Sarcoma Treatment Revenue (2021-2032)
  8. 7.2.2 North America Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Synovial Sarcoma Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Synovial Sarcoma Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Synovial Sarcoma Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Synovial Sarcoma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Synovial Sarcoma Treatment Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Synovial Sarcoma Treatment Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Merck & Co Inc
  14. 8.3.1 Merck & Co Inc Company Information
  15. 8.3.2 Merck & Co Inc Business Overview
  16. 8.3.3 Merck & Co Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co Inc Synovial Sarcoma Treatment Product Portfolio
  18. 8.3.5 Merck & Co Inc Recent Developments
  19. 8.4 Pfizer Inc
  20. 8.4.1 Pfizer Inc Company Information
  21. 8.4.2 Pfizer Inc Business Overview
  22. 8.4.3 Pfizer Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc Synovial Sarcoma Treatment Product Portfolio
  24. 8.4.5 Pfizer Inc Recent Developments
  25. 8.5 Takara Bio Inc
  26. 8.5.1 Takara Bio Inc Company Information
  27. 8.5.2 Takara Bio Inc Business Overview
  28. 8.5.3 Takara Bio Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Takara Bio Inc Synovial Sarcoma Treatment Product Portfolio
  30. 8.5.5 Takara Bio Inc Recent Developments
  31. 8.6 Millennium Pharmaceuticals Inc
  32. 8.6.1 Millennium Pharmaceuticals Inc Company Information
  33. 8.6.2 Millennium Pharmaceuticals Inc Business Overview
  34. 8.6.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product Portfolio
  36. 8.6.5 Millennium Pharmaceuticals Inc Recent Developments
  37. 8.7 Karyopharm Therapeutics Inc
  38. 8.7.1 Karyopharm Therapeutics Inc Company Information
  39. 8.7.2 Karyopharm Therapeutics Inc Business Overview
  40. 8.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product Portfolio
  42. 8.7.5 Karyopharm Therapeutics Inc Recent Developments
  43. 8.8 Immunocore Ltd
  44. 8.8.1 Immunocore Ltd Company Information
  45. 8.8.2 Immunocore Ltd Business Overview
  46. 8.8.3 Immunocore Ltd Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Immunocore Ltd Synovial Sarcoma Treatment Product Portfolio
  48. 8.8.5 Immunocore Ltd Recent Developments
  49. 8.9 Immune Design Corp
  50. 8.9.1 Immune Design Corp Company Information
  51. 8.9.2 Immune Design Corp Business Overview
  52. 8.9.3 Immune Design Corp Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Immune Design Corp Synovial Sarcoma Treatment Product Portfolio
  54. 8.9.5 Immune Design Corp Recent Developments
  55. 8.10 EpiZyme Inc
  56. 8.10.1 EpiZyme Inc Company Information
  57. 8.10.2 EpiZyme Inc Business Overview
  58. 8.10.3 EpiZyme Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EpiZyme Inc Synovial Sarcoma Treatment Product Portfolio
  60. 8.10.5 EpiZyme Inc Recent Developments
  61. 8.11 Advenchen Laboratories LLC
  62. 8.11.1 Advenchen Laboratories LLC Company Information
  63. 8.11.2 Advenchen Laboratories LLC Business Overview
  64. 8.11.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Advenchen Laboratories LLC Synovial Sarcoma Treatment Product Portfolio
  66. 8.11.5 Advenchen Laboratories LLC Recent Developments
  67. 8.12 Adaptimmune Therapeutics Plc
  68. 8.12.1 Adaptimmune Therapeutics Plc Company Information
  69. 8.12.2 Adaptimmune Therapeutics Plc Business Overview
  70. 8.12.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product Portfolio
  72. 8.12.5 Adaptimmune Therapeutics Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Synovial Sarcoma Treatment Value Chain Analysis
  2. 9.1.1 Synovial Sarcoma Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Synovial Sarcoma Treatment Production Mode & Process
  6. 9.2 Synovial Sarcoma Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Synovial Sarcoma Treatment Distributors
  9. 9.2.3 Synovial Sarcoma Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst